Persistant post-covid 19 intertitial lung disease

Abstract

The follow-up of the sequelae of patients declared cured of severe COVID lung disease has been organized in many hospitals, in particular at the Mohammed VI University Hospital in Marrakech, Morocco. The objective of this study is to evaluate the clinical, scannographic and respiratory functional sequelae at 3 months according to the severity of the initial damage. It is a monocentric prospective observational study using data from computerized medical records. We organized the 3-month follow-up of patients of the 3rd wave cured of severe COVID: clinical evaluation, lung scans, respiratory function tests (RFTs). This study includes five patients with persistant inflammatory interstital lung disease (ILD) following SARS-CoV-2 when treated with prednisolone.